Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Organic Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115233243B reveals green electrocatalytic synthesis for oxazoles. Eliminates noble metals, reduces cost, ensures supply chain stability for pharma intermediates.
Patent CN116986969B enables high-purity fluoroallyl alcohol via photocatalysis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced photocatalytic synthesis of sulfone-ylated gamma-lactones. High yield, mild conditions, cost-effective supply chain solutions for pharma intermediates.
A novel metal-free photocatalytic method for preparing deuterated intermediates using visible light, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel patent CN115197096B offers high-yield valsartan intermediate synthesis. Reduces dimer impurities, ensures supply chain stability for pharmaceutical manufacturing.
Patent CN116730916B reveals a green photocatalytic route for 6-methylphenanthridine. Offers high yield, mild conditions, and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN115011974B reveals green electrocatalytic route for trans-allyl benzene compounds, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN116874461A reveals room temperature photocatalytic route for sultones. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN115233243A reveals a green electrocatalytic route for 2,4,5-trisubstituted oxazoles, offering cost reduction and simplified supply chains for pharmaceutical intermediates.
Patent CN116924866A reveals a green photocatalytic method for internal alkyne synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.